Atlas Trials

Treprostinil Sodium Inhalation for Patients At High Risk for ARDS

Clinical trial NCT02370095 · TERMINATED

Trial details

NCT number
NCT02370095
Sponsor
University of North Carolina, Chapel Hill
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Distress Syndrome, Adult
Start date
2015-02-01
Primary completion
2017-10-11
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.